Does LEVOMILNACIPRAN Cause C-reactive protein abnormal? 33 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of C-reactive protein abnormal have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 2.4% of all adverse event reports for LEVOMILNACIPRAN.
33
Reports of C-reactive protein abnormal with LEVOMILNACIPRAN
2.4%
of all LEVOMILNACIPRAN reports
33
Deaths
33
Hospitalizations
How Dangerous Is C-reactive protein abnormal From LEVOMILNACIPRAN?
Of the 33 reports, 33 (100.0%) resulted in death, 33 (100.0%) required hospitalization, and 33 (100.0%) were considered life-threatening.
Is C-reactive protein abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause C-reactive protein abnormal?
METHOTREXATE (3,734)
ADALIMUMAB (3,629)
ETANERCEPT (3,592)
ABATACEPT (3,402)
LEFLUNOMIDE (3,279)
TOCILIZUMAB (3,259)
HYDROXYCHLOROQUINE (3,245)
SULFASALAZINE (2,823)
INFLIXIMAB (2,676)
RITUXIMAB (2,608)
Which LEVOMILNACIPRAN Alternatives Have Lower C-reactive protein abnormal Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE